SHAREHOLDER ALERT: The M&A Class Action Investigates the Merger of Asensus Surgical, Inc. - ASXC

Core Viewpoint - Monteverde & Associates PC is investigating Asensus Surgical, Inc. regarding its proposed merger with KARL STORZ Endoscopy-America, Inc., which involves acquiring each outstanding share of Asensus Surgical stock for $0.35 in cash [1] Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report and has a successful track record in recovering money for shareholders [1][2] - The firm operates from the Empire State Building in New York City and specializes in class action securities litigation [2] Merger Details - The merger agreement stipulates that KARL STORZ Endoscopy-America, Inc. and Karl Storz California Inc. will acquire Asensus Surgical shares at a price of $0.35 per share, without interest [1]